Aparicio, Carlos http://orcid.org/0000-0002-2069-691X
Polido, Waldemar D.
Chehade, Antoine
Shenouda, Marc
Simon, Madalina
Simon, Peter
Al-Nawas, Bilal
Article History
Received: 26 February 2024
Accepted: 21 May 2024
First Online: 10 June 2024
Declarations
:
: This is a prospective, non-interventional study. The study participants were consecutive patients with indications for zygomatic implants. All participants signed an informed consent to undergo zygomatic surgery and prosthetic rehabilitation. In its initial phase, the Indiana University HRPP staff determined (Protocol#:12562) that the present study is not human subjects research and does not require additional IRB review. All procedures were performed according to the 1964 Declaration of Helsinki’s ethical standards and subsequent amendments or comparable ethical standards.
: All data published here are under the consent for publication.
: Carlos Aparicio is the founding president of Zygoma ZAGA Centers and occasionally provides CE activities for NobelBiocare, Straumann Group, SouthernImplants and Versah Osseodensification Company. Waldemar Polido occasionally performs CE activities for Straumann Group and Geistlich Biomaterials. Bilal Al-Nawas occasionally performs CE activities and obtains research grants for StraumannGroup, BEGO, Camlog, Dentsply and Geistlich Biomaterials. All other authors declare that they have no conflicts of interest.